$61.69 -2.39 (%) Integra Lifesciences Holdings Corp - NASDAQ

Aug. 4, 2015 | 03:40 PM

Partner Headlines

  1. Mid-Morning Market Update: Markets Edge Higher; Centene To Acquire Health Net For $6.3B

    Benzinga | Jul. 2, 2015 | 11:05AM EST
  2. Must Watch Stocks for June 29, 2015

    Benzinga | Jun. 29, 2015 | 05:53AM EST
  3. Benzinga's Weekend M&A Chatter

    Benzinga | Jun. 28, 2015 | 20:20PM EST
  4. Integra LifeSciences to Acquire TEI Biosciences and TEI Medical For $312M In Cash

    Benzinga | Jun. 28, 2015 | 10:01AM EST
  5. UPDATE: Integra LifeSciences Announces FDA Clearance And Controlled Market Release Of Expandable Interbody System For Spinal Surgery

    Benzinga | Nov. 13, 2014 | 08:51AM EST
  6. EMCORE Selling Space Solar Business to Veritas Capital

    FoxBusiness | Sep. 22, 2014 | 08:00AM EST
  7. Integra LifeSciences Announces Changes Within Its Orthopedics And Tissue Technologies Business

    Benzinga | Sep. 2, 2014 | 08:01AM EST
  8. Integra LifeSciences Announces Renewal And Extension Of Credit Facility; Increased From $600M to $900M

    Benzinga | Jul. 9, 2014 | 16:19PM EST
  9. Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges

    Benzinga | Feb. 27, 2014 | 08:35AM EST
  10. Morgan Stanley Sees Focus & Efficiency as Key for Integra Lifesciences

    Benzinga | Feb. 26, 2014 | 10:15AM EST
  11. UPDATE: Morgan Stanley Upgrades Integra LifeSciences Holdings Following Acquisition of Confluent Surgical

    Benzinga | Nov. 11, 2013 | 09:39AM EST
  12. Covidien Q4 Meets Estimates, But Gross Margins Miss

    IBD | Nov. 8, 2013 | 11:41AM EST
  13. Integra LifeSciences Prices 3.5M Share Offering at $40.00/Share

    Benzinga | Nov. 6, 2013 | 21:54PM EST
  14. INTEGRA LIFESCIENCES

    IBD | Oct. 28, 2013 | 18:49PM EST
  15. UPDATE: Morgan Stanley Downgrades Integra Lifesciences Holdings Corp. as Cash Generation and 2014 Consensus EPS Are at Risk

    Benzinga | Oct. 23, 2013 | 10:11AM EST
  16. UPDATE: Integra Lifesciences Wins FDA 510(K) Clearance for C3-T3

    Benzinga | Oct. 10, 2013 | 08:33AM EST
  17. UPDATE: Integra Wins 510(K) Clearance for Hollywood Nanometalene IBD

    Benzinga | Oct. 9, 2013 | 08:34AM EST
  18. Integra LifeSciences Announces Podium Presentation of NeuraGen(R) Nerve Guide Multi-Center Clinical Trial at ASSH

    Benzinga | Oct. 2, 2013 | 08:33AM EST
  19. Integra LifeSciences Holdings Corporation Appoints Donald E. Morel, Jr., Ph.D. as a Director and Announces Retirement of Neal Moszkowski as a Director

    Benzinga | Aug. 27, 2013 | 16:05PM EST
  20. WEEKLY CFO SELLS HIGHLIGHT: LMT, WCG, GRPN, IART, CNK

    GuruFocus | Aug. 26, 2013 | 11:04AM EST
  21. Market Wrap For Thursday, August 15: Stocks Plunge Amid Fears Of Fed Tapering

    Benzinga | Aug. 15, 2013 | 18:31PM EST
  22. UPDATE: Piper Jaffray Upgrades Integra LifeSciences On FDA Inspection Results

    Benzinga | Aug. 15, 2013 | 07:56AM EST
  23. Benzinga's Top Upgrades

    Benzinga | Aug. 15, 2013 | 07:34AM EST
  24. Integra Lifesciences Wins CE Mark Certification for Flowable Wound Matrix

    Benzinga | Jan. 18, 2013 | 01:31AM EST
  25. UPDATE: JP Morgan Maintains Integra LifeSciences at Neutral Following Model Update

    Benzinga | Dec. 27, 2012 | 06:58AM EST
  26. Integra LifeSciences Receives Warning Letter from FDA

    Benzinga | Nov. 12, 2012 | 23:16PM EST
  27. Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device

    Benzinga | Oct. 9, 2012 | 02:09AM EST
  28. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 25, 2012 | 04:21AM EST
  29. Integra LifeSciences Holdings Corp. (IART) EVP, Finance & Admin & CFO John B Iii ...

    GuruFocus | Aug. 13, 2012 | 13:27PM EST
  30. UPDATE: Jefferies Raises PT on Integra Life-Sciences Holdings from $40 to $43

    Benzinga | Jul. 27, 2012 | 05:39AM EST
  31. UPDATE: Bank of America Raises PO to $40 on Integra Lifesciences

    Benzinga | Jun. 27, 2012 | 04:01AM EST
  32. Integra LifeSciences Announces Contract With aap Implantate AG to Provide Stainless Headed Compression Screws for Mid and Hindfoot Reconstruction

    Benzinga | Jun. 21, 2012 | 00:27AM EST
  33. Barrington Research Reiterates Integra LifeSciences Outperform, $50 PT

    Benzinga | Feb. 28, 2012 | 08:44AM EST
  34. Integra LifeSciences Holdings Corp. Reports Operating Results (10-K)

    GuruFocus | Feb. 27, 2012 | 10:14AM EST
  35. Benzinga's Top Downgrades

    Benzinga | Dec. 23, 2011 | 01:58AM EST
  36. UPDATE: Disclosure Insight Downgrades Integra Lifesciences to Medium Risk - Negative Bias

    Benzinga | Dec. 23, 2011 | 00:23AM EST
  37. Piper Jaffray Reiterates Neutral, $38 PT on Integra LifeSciences

    Benzinga | Dec. 22, 2011 | 00:21AM EST
  38. Jefferies Provides Color On Integra LifeSciences Holdings

    Benzinga | Dec. 21, 2011 | 09:29AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!